Zai Lab (Pending:ZLAB) priced its upsized IPO at the high end of the range, raising $150 million. Insiders bought $18 million on the offering (12% of the deal). The Chinese cancer biotech plans to commercialize three late-stage candidates in Hong Kong …
( read original story …)